Prostate cancer trials in United States

In United States 658 Also abroad 1481

658 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseEnrolling by invitation
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
Where
Bethesda
Age
18 years to 120 years
People
3,894
Run by
National Institutes of Health Clinical Center (CC)
See details and how to joinNCT00102544
Phase 2Taking people
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Where
Boston, Grand Rapids, Houston, Los Angeles, Nashville, New Haven, Newton, Trumbull
Age
18 years and over
People
430 worldwide
Run by
Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00
No phaseTaking people
Prostate Cancer Genetic Risk Evaluation and Screening Study
Where
Boston
Age
35 years and over
People
400
Run by
Massachusetts General Hospital
See details and how to joinNCT05129605
No phaseTaking people
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
Where
Bethesda
Age
18 years and over
People
350
Run by
National Cancer Institute (NCI)
See details and how to joinNCT05588128
Phase 2Taking people
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Where
Bethesda
Age
18 years to 120 years
People
41
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06161506
No phaseEnrolling by invitation
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Where
Bethesda
Age
18 years to 99 years
People
64,277
Run by
National Cancer Institute (NCI)
See details and how to joinNCT07328516
Phase 1Taking people
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Where
Austin, Celebration, Denver, Detroit, Duarte, East Brunswick, Fairfax, Fort Worth, Houston, Irvine, Irving, Lake Success, Nashville, New Haven, New York, Plantation, San Antonio, Sarasota, Spokane, West Valley City
Age
18 years and over
People
150 worldwide
Run by
IDEAYA Biosciences
See details and how to joinNCT07503808 · EU 2026-526299-21-00
Phase 2Taking people
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
Where
Bethesda
Age
18 years to 120 years
People
52
Run by
National Cancer Institute (NCI)
See details and how to joinNCT07574541
Phase 1/2Taking people
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Where
Bethesda
Age
18 years to 120 years
People
120
Run by
National Cancer Institute (NCI)
See details and how to joinNCT07667400
Phase 1/2Not yet taking people in United States
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
Where
Bethesda
Age
18 years to 120 years
People
67
Run by
National Cancer Institute (NCI)
See details and how to joinNCT07902921
No phaseNot yet taking people in United States
MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment
Where
Detroit
Age
18 years to 70 years
People
100
Run by
Barbara Ann Karmanos Cancer Institute
See details and how to joinNCT07928154
No phaseTaking people
Collection of Blood From Patients With Cancer
Where
Bethesda
Age
18 years and over
People
1,750
Run by
National Cancer Institute (NCI)
See details and how to joinNCT00034216
No phaseTaking people
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Where
Bethesda
Age
18 years and over
People
750
Run by
National Cancer Institute (NCI)
See details and how to joinNCT00451022
No phaseTaking people
Collection of Blood From Patients With Prostate Cancer
Where
Bethesda
Age
18 years and over
People
1,000
Run by
National Cancer Institute (NCI)
See details and how to joinNCT00923221
No phaseTaking people
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Where
Bethesda
Age
18 years to 120 years
People
300
Run by
National Cancer Institute (NCI)
See details and how to joinNCT01834001
No phaseTaking people
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
Where
Bethesda
Age
18 years and over
People
3,000
Run by
National Cancer Institute (NCI)
See details and how to joinNCT02594202
No phaseTaking people
Diffusion Basis Spectrum Imaging of the Prostate
Where
St Louis
Age
18 years and over
People
500
Run by
Washington University School of Medicine
See details and how to joinNCT04420702
Phase 1Taking people
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
Where
Duarte
Age
18 years and over
People
21
Run by
City of Hope Medical Center
See details and how to joinNCT05805371
No phaseTaking people
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
Where
Ann Arbor
Age
40 years to 80 years
People
50
Run by
University of Michigan Rogel Cancer Center
See details and how to joinNCT05965180
Phase 2Taking people
Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer
Where
Salt Lake City
Age
18 years and over
People
160
Run by
University of Utah
See details and how to joinNCT07216248
No phaseTaking people
Circulating Tumor DNA in High Risk Localized Prostate Cancer
Where
Pittsburgh
Age
18 years and over
People
24
Run by
University of Pittsburgh
See details and how to joinNCT07222436
Phase 1/2Taking people
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Where
Grand Rapids, La Jolla, Los Angeles, Philadelphia, West Valley City
Age
18 years and over
People
54 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07332455
Phase 1/2Taking people
GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)
Where
New York
Age
18 years and over
People
107 worldwide
Run by
GI Innovation, Inc.
See details and how to joinNCT07871435
Phase 2Not yet taking people in United States
PSMA PET/MRI for Predicting and Detecting Prostate Cancer
Where
Madison
Age
18 years to 85 years
People
120
Run by
University of Wisconsin, Madison
See details and how to joinNCT07924605
Phase 2Not yet taking people in United States
Study of Ifinatamab Deruxtecan in De Novo or Treatment-Emergent Neuroendocrine Prostate Cancer
Where
San Francisco
Age
18 years and over
People
30
Run by
Rahul Aggarwal
See details and how to joinNCT07925268